Therapie mit THYMEX-L und TFX THYMOMODULIN in der Praxis

Journal/Book: Erfahrungsheilkunde. 1989; 38/8: 500-503.

Abstract: The author will explain the differences between cell therapy and thymus therapy, excluding criticism of cell therapy and setting standards of appraisal. He will report about total thymus extract, showing how a modern laboratory of production of thymus preparations should look like.Then the author will discuss THX/ THYMEX-L preparation. He will indicate composition and function of the drug as well as the range of application. It is obvious that the range of application includes all diseases due to reduced immunity. The positive experiences in treatment of AIDS-patients made in Kinshasa/Zaire will be commented, too.Furthermore contra- indications of Thymex-L will be indicated. In particular these are application of cortisone and other hormones, homeostatic coagulation disturbance, internal hemorrhage of undetermined origin and the first 3 months of pregnancy. Following side effects may occur: local redness, swellings or itching and in some cases fever or shivering. To avoid interactions Pesic recommends not to combine treatment of Thymex-L with high doses of preparations containing salicylic acid.Next the exact dosage of whole thymus extract for various diseases will be explained. The standard treatment contains 15-20 injections within a period of 3-4 weeks.The author will report about the application of Thymex-L and for interested colleagues he will give a survey about the possibilities in participating in the clinical tests with Thymex-L.Finally, the differences in indication and range of application between Thymex-L and TFX THYMOMODULIN will be explained. Attention is drawn to the fact that the approval of the Federal Board of Health for clinical tests with TFX Thymomodulin is in preparation.This report is annexed by a detailed list of literature.

Zurück | Weiter